, Volume 40, Issue 9, pp 919–923

Dietary sitostanol and campestanol: Accumulation in the blood of humans with sitosterolemia and xanthomatosis and in rat tissues

  • William E. Connor
  • Don S. Lin
  • Anuradha S. Pappu
  • Jiri Frohlich
  • Glenn Gerhard


Dietary sitostanol has a hypocholesterolemic effect because it decreases the absorption of cholesterol. However, its effects on the sitostanol concentrations in the blood and tissues are relatively unknown, especially in patients with sitosterolemia and xanthomatosis. These patients hyperabsorb all sterols and fail to excrete ingested sitosterol and other plant sterols as normal people do. The goal of the present study was to examine the absorbability of dietary sitostanol in humans and animals and its potential long-term effect. Two patients with sitosterolemia were fed the margarine Benecol (McNeill Nutritionals, Ft. Washington, PA), which is enriched in sitostanol and campestanol, for 7–18 wk. Their plasma cholesterol levels decreased from 180 to 167 mg/dL and 153 to 113 mg/dL, respectively. Campesterol and sitosterol also decreased. However, their plasma sitostanol levels increased from 1.6 to 10.1 mg/dL and from 2.8 to 7.9 mg/dL, respectively. Plasma campestanol also increased. After Benecol withdrawal, the decline in plasma of both sitostanol and campestanol was very sluggish. In an animal study, two groups of rats were fed high-cholesterol diets with and without sitostanol for 4 wk. As expected, plasma and liver cholesterol levels decreased 18 and 53%, respectively. The sitostanol in plasma increased fourfold, and sitostanol increased threefold in skeletal muscle and twofold in heart muscle. Campestanol also increased significantly in both plasma and tissues. Our data indicate that dietary sitostanol and campestanol are absorbed by patients with sitosterolemia and xanthomatosis and also by rats. The absorbed plant stanols were deposited in rat tissues. Once absorbed by sitosterolemic patients, the prolonged retention of sitostanol and campestanol in plasma might increase their atherogenic potential.



ATP binding cassette


General Clinical Research Centers


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Peterson, D.N. (1951) Effects of Soybean Sterols in the Diet on Plasma and Liver Cholesterol in Chicks, Proc. Soc. Exp. Biol. Med. 78, 143–147.PubMedGoogle Scholar
  2. 2.
    Pollak, O.J., and Kritchevsky, D. (1981) Sitosterol, in Monographs on Atherosclerosis (Clarkson, T.B., Kritchevsky, D., and Pollak, O.J., eds.) Vol. 10, S. Karger, Basal.Google Scholar
  3. 3.
    Lees, A.M., Mok, H.Y., Lees, R.S., McCluskey, M.A., and Grundy, S.M. (1977) Plant Sterols As Cholesterol-Lowering Agents: Clinical Trials in Patients with Hypercholesterolemia and Studies of Sterol Balance, Atherosclerosis 28, 325–338.PubMedCrossRefGoogle Scholar
  4. 4.
    Lutjohann, D., Bjorkhem, I., Beil, U.F., and von Bergmann, K. (1995) Sterol Absorption and Sterol Balance in Phytosterolemia Evaluated by Deuterium-Labeled Sterols: Effect of Sitostanol Treatment, J. Lipid Res. 36, 1763–1773.PubMedGoogle Scholar
  5. 5.
    Vanhaven, H.T., Kajander, J., Lehtovirta, H., and Miettinen, T.A. (1994) Serum Levels, Absorption Efficiency, Fecal Elimination and Synthesis of Cholesterol During Increasing Doses of Dietary Sitostanol Esters in Hypercholesterolemic Subjects, Clin. Sci. 87, 61–67.Google Scholar
  6. 6.
    Heinemann, I.G., Kullak-Ublick, A., Pietruck, B., and von Bergmann, K. (1991) Mechanisms of Action of Plant Sterols on Inhibition of Cholesterol Absorption, Eur. J. Clin. Pharmacol. 40 (Suppl. 1), 559–563.Google Scholar
  7. 7.
    Miettinen, T.A., Puska, P., Gylling, H., Vanhanen, H., and Vartiainen, E. (1995) Reduction of Serum Cholesterol with Sitostanol Ester Margarine in a Mildly Hypercholesterolemic Population, N. Engl. J. Med. 333, 1308–1312.PubMedCrossRefGoogle Scholar
  8. 8.
    Becker, M., Staab, D., and Von Bergmann, K. (1993) Treatment of Severe Familial Hypercholesterolemia in Children with Sitosterol and Sitostanol, J. Pediatr. 122, 292–296.PubMedGoogle Scholar
  9. 9.
    Jones, P.J., Rasini-Sarjaz, M., Ntarios, F.Y., Vanstone, C.A., Feng, J.G., and Parsons, W.E. (2000) Modulation of Plasma Lipid Levels and Cholesterol Kinetics by Phytosterol Versus Phytostanol Esters, J. Lipid Res. 41, 697–705.PubMedGoogle Scholar
  10. 10.
    Bhattacharyya, A.K., and Connor, W.E. (1974) Sitosterolemia and Xanthomatosis: A Newly Described Lipid Disease in Two Sisters, J. Clin. Invest. 53, 1033–1043.PubMedCrossRefGoogle Scholar
  11. 11.
    Salen, G., Horak, I., Rothkopf, M., Cohen, J.L., Speck, J., Tint, G.S., Shore, V., Dayal, B., Chen, T., and Shefer, S. (1985) Lethal Atherosclerosis Associated with Abnormal Plasma and Tissue Sterol Composition in Sitosterolemia with Xanthomatosis, J. Lipid Res. 26, 1126–1132.PubMedGoogle Scholar
  12. 12.
    Miettinen, T.A. (1980) Phytositosterolemia, Xanthomatosis and Pre Mature Atherosclerotic Arterial Disease, a Case with High Plant Sterol Absorption, Impaired Sterol Elimination and Low Cholesterol Synthesis, Eur. J. Clin. Invest. 10, 27–35.PubMedGoogle Scholar
  13. 13.
    Salen, G., Kwiterovich, P.O., Jr., Shefer, S., Tint, G.S., Horak, I., Shore, V., Dayal, B., and Horak, E. (1985) Increased Plasma Cholestanol and 5 Alpha-Saturated Plant Sterol Derivatives in Subjects with Sitosterolemia and Xanthomatosis, J. Lipid Res. 26, 203–209.PubMedGoogle Scholar
  14. 14.
    Wang, E., Lin, H.J., Chan, T.K., Salen, G., Chan, W.C., and Tse, T.F. (1981) A Unique Patient with Coexisting Cerebrotendinous Xanthomatosis and β-Sitosterolemia, Am. J. Med. 71, 313–319.PubMedCrossRefGoogle Scholar
  15. 15.
    Altmann, S.W., Davis, H.R., Jr., Zhu, L.J., Yao, X., Hoos, L.M., Tetzloff, G., Iyer, S.P., Maguire, M., Golovko, A., Zeng, M., et al. (2004) Niemann-Pick C1 Like 1 Protein Is Critical for Intestinal Cholesterol Absorption, Science 303, 1201–1202.PubMedCrossRefGoogle Scholar
  16. 16.
    Berge, K.E., Tian, H., Graf, G.A., Yu, L., Grishin, N.V., Schultz, J., Kwiterovich, P., Shan, B., Barnes, R., and Hobbs, H.H. (2000) Accumulation of Dietary Cholesterol in Sitosterolemia Caused by Mutations in Adjacent ABC Transporters, Science 290, 1771–1775.PubMedCrossRefGoogle Scholar
  17. 17.
    Lee, M.H., Lu, K., Hazard, S., Yu, H., Shulenin, S., Hidaka, H., Kojima, H., Allikmets, R., Sakuma, N., Sakuma, N., et al. (2001) Identification of a Gene, ABCG5, Important in the Regulation of Dietary Cholesterol Absorption, Nat. Genet. 27, 79–83.PubMedCrossRefGoogle Scholar
  18. 18.
    Kwiterovich, P.O., Chen, S.C., Virgil, D.G., Schweitzer, A., Arnold, D.R., and Kratz, L.E. (2003) Response of Obligate Heterozygotes for Phytosterolemia to a Low-Fat Diet and to a Plant Sterol Ester Dietary Challenge, J. Lipid Res. 44, 1143–1155.PubMedCrossRefGoogle Scholar
  19. 19.
    Connor, W.E., Lin, D.S., Wolf, D.P., and Alexander, M. (1998) Unique Distribution of Desmosterol and Docosahexaenoic Acid in the Heads and Tails of Monkey Sperm, J. Lipid Res. 39, 1404–1411.PubMedGoogle Scholar
  20. 20.
    Folch, J., Lees, M.B., and Sloane Stanley, G.H. (1957) Method for the Isolation and Purification of Total Lipids from Animal Tissues, J. Biol. Chem. 226, 497–509.PubMedGoogle Scholar
  21. 21.
    SPSS Statistical Version 10. SPSS Inc., Chicago.Google Scholar
  22. 22.
    Glueck, C.T., Speirs, J., Streicher, P., Illig, E., and Vandegroft, J. (1991) Relationships of Serum Plant Sterols (phytosterols) and Cholesterol in 595 Hypercholesterolemic Subjects and Familial Aggregation of Phytosterols, Cholesterol and Premature Coronary Heart Decrease in Hypercholesterolemic Probands and Their First Degree Relatives, Metabolism 40, 842–848.PubMedCrossRefGoogle Scholar
  23. 23.
    Small, D.M., and Shipley, G.G. (1974) Physical-chemical Basis of Lipid Deposition in Atherosclerosis. The Physical State of the Lipids Helps to Explain Lipid Deposition and Lesion Reversal in Atherosclerosis, Science 185, 222–229.PubMedCrossRefGoogle Scholar
  24. 24.
    Bhattacharyya, A.K., Connor, W.E., Lin, D.S., McMurry, M.M., and Shulman, R.S. (1991) Sluggish Sitosterol Turnover and Hepatic Failure to Excrete Sitosterol into Bile Cause Expansion of Body Pool of Sitosterol in Patients with Sitosterolemia and Xanthomatosis, Arterioscler. Thromb. 11, 1287–1294.PubMedGoogle Scholar
  25. 25.
    Salen, G., von Bergmann, K., Lutjohann, D., Kwiterovich, P., Kane, J., Patel, S.B., Musliner, T., Stein, P., Musser, B., and Multicenter Sitosterolemia Study Group (2004) Ezetimibe Effectively Reduces Plasma Plant Sterols in Patients with Sitosterolemia, Circulation 109, 966–971.PubMedCrossRefGoogle Scholar
  26. 26.
    Borgström, B. (1968) Quantitative Aspects of the Intestinal Absorption and Metabolism of Cholesterol and β-Sitosterol in the Rat, J. Lipid Res. 9, 473–481.PubMedGoogle Scholar
  27. 27.
    Connor, W.E., and Lin, D.S. (1974) The Intestinal Absorption of Dietary Cholesterol by Hypercholesterolemic (Type II) and Normocholesterolemic Humans, J. Clin. Invest. 53, 1062–1070.PubMedGoogle Scholar
  28. 28.
    Connor, W.E., Dietary Sterols: Their Relationship to Atherosclerosis, (1968). J. Am. Diet. Assoc. 52, 202–208.PubMedGoogle Scholar
  29. 29.
    Bhattacharyya, A.K., and Connor, W.E. (1997) Familial Diseases with Storage of Sterols Other Than Cholesterol, Cerebrotendinous Xanthomatosis, Sitosterolemia and Xanthomatosis, in The Metabolic Basis of Inherited Disease (Standbury, J.B., Wyngaarden, J.D., and Fredrickson, D.S., eds.), 4th edn., pp. 656–669, McGraw-Hill, New York.Google Scholar

Copyright information

© AOCS Press 2005

Authors and Affiliations

  • William E. Connor
    • 1
  • Don S. Lin
    • 1
  • Anuradha S. Pappu
    • 1
  • Jiri Frohlich
    • 2
  • Glenn Gerhard
    • 1
  1. 1.Division of Endocrinology, Diabetes and Clinical Nutrition, Department of MedicineOregon Health & Science UniversityPortland
  2. 2.Healthy Heart Program, St. Paul's HospitalThe University of British ColumbiaVancouverCanada

Personalised recommendations